Drug-resistant malaria is becoming more common and there is increased interest in possible solutions from pharmaceutical companies. The greater the range of action against multiple strains of malaria plasmodium will lead to a greater success rate for the newly developed drugs. However, pricing strategy will be crucial to the uptake of new antimalarial treatments.
Egyptian drugmakers will be given a boost as measures to raise the price of a number of essential medicines are imposed by the Ministry of Health. The agreement to include chronic disease treatments within the basket of drugs set for price increases has important implications for the population's access to long-term illness medications. Over the long-term, Egypt's medicine supply remains precar...
Healthcare will remain a priority in the UAE despite a stagnant federal budget for 2017. Continued government investment into the various social sectors, economic growth from the non-oil sector and improved intellectual property legislation mean that the UAE will remain an attractive pharmaceutical market for innovative pharmaceutical companies.
A member of our Client Services team will be in touch soon to arrange a convenient time for a free demonstration of the service. If your enquiry is urgent, please email our team here.
Thanks, BMI Research